메뉴 건너뛰기




Volumn 164, Issue 1, 2004, Pages 107-108

Risks and Benefits of Statins in Lupus Erythematosus [3]

(1)  Noël, Bernard a  

a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; AUTOANTIBODY; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SIMVASTATIN; STATINE DERIVATIVE;

EID: 0346057969     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.164.1.107-b     Document Type: Letter
Times cited : (10)

References (11)
  • 1
    • 0037480240 scopus 로고    scopus 로고
    • The cardiovascular burden of lupus: A complex challenge
    • Schattner A, Liang MH. The cardiovascular burden of lupus: a complex challenge. Arch Intern Med. 2003; 163: 1507-1510.
    • (2003) Arch Intern Med , vol.163 , pp. 1507-1510
    • Schattner, A.1    Liang, M.H.2
  • 4
    • 0032569489 scopus 로고    scopus 로고
    • Lupus-like syndrome associated with simvastatin
    • Hanson J, Bossingham D. Lupus-like syndrome associated with simvastatin [letter]. Lancet. 1998;352:1070.
    • (1998) Lancet , vol.352 , pp. 1070
    • Hanson, J.1    Bossingham, D.2
  • 5
    • 0037231631 scopus 로고    scopus 로고
    • Drug-induced, Ro/SSA-positive cutaneous lupus erythematosus
    • Srivastana M, Rencic A, Diglio G, et al. Drug-induced, Ro/SSA-positive cutaneous lupus erythematosus. Arch Dermatol. 2003;139:45-49.
    • (2003) Arch Dermatol , vol.139 , pp. 45-49
    • Srivastana, M.1    Rencic, A.2    Diglio, G.3
  • 6
    • 0038240975 scopus 로고    scopus 로고
    • Drug-induced lupus-like syndrome associated with severe autoimmune hepatitis
    • Graziadei IW, Obermoser GE, Sepp NT, Erhart KH, Vogel W. Drug-induced lupus-like syndrome associated with severe autoimmune hepatitis. Lupus. 2003;12:409-412.
    • (2003) Lupus , vol.12 , pp. 409-412
    • Graziadei, I.W.1    Obermoser, G.E.2    Sepp, N.T.3    Erhart, K.H.4    Vogel, W.5
  • 9
    • 0034283536 scopus 로고    scopus 로고
    • Inhibitors of HMG-CoA reductase sensitize human smooth muscle cells to Fas-ligand and cytokine-induced cell death
    • Knapp AC, Huang J, Starling G, Kiener PA. Inhibitors of HMG-CoA reductase sensitize human smooth muscle cells to Fas-ligand and cytokine-induced cell death. Atherosclerosis. 2000;152:217-227.
    • (2000) Atherosclerosis , vol.152 , pp. 217-227
    • Knapp, A.C.1    Huang, J.2    Starling, G.3    Kiener, P.A.4
  • 10
    • 0034533147 scopus 로고    scopus 로고
    • Statins as a newly recognized type of immunomodulator
    • Kwak B, Mulhaupt F, Myit S, Mach F. Statins as a newly recognized type of immunomodulator. Nat Med. 2000;6:1399-1402.
    • (2000) Nat Med , vol.6 , pp. 1399-1402
    • Kwak, B.1    Mulhaupt, F.2    Myit, S.3    Mach, F.4
  • 11
    • 0037038402 scopus 로고    scopus 로고
    • The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease
    • Youssef S, Stuve O, Patarroyo JC, et al. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature. 2002;420:78-84.
    • (2002) Nature , vol.420 , pp. 78-84
    • Youssef, S.1    Stuve, O.2    Patarroyo, J.C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.